Zielińska, A.; Sobolewska-Włodarczyk, A.; Wiśniewska-Jarosińska, M.; Gąsiorowska, A.; Fichna, J.; Sałaga, M.
The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency. Pharmaceuticals 2021, 14, 284.
https://doi.org/10.3390/ph14030284
AMA Style
Zielińska A, Sobolewska-Włodarczyk A, Wiśniewska-Jarosińska M, Gąsiorowska A, Fichna J, Sałaga M.
The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency. Pharmaceuticals. 2021; 14(3):284.
https://doi.org/10.3390/ph14030284
Chicago/Turabian Style
Zielińska, Anna, Aleksandra Sobolewska-Włodarczyk, Maria Wiśniewska-Jarosińska, Anita Gąsiorowska, Jakub Fichna, and Maciej Sałaga.
2021. "The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency" Pharmaceuticals 14, no. 3: 284.
https://doi.org/10.3390/ph14030284
APA Style
Zielińska, A., Sobolewska-Włodarczyk, A., Wiśniewska-Jarosińska, M., Gąsiorowska, A., Fichna, J., & Sałaga, M.
(2021). The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency. Pharmaceuticals, 14(3), 284.
https://doi.org/10.3390/ph14030284
